Terms: = Kidney tumors AND BAP1, DKFZp686N04275, 8314, ENSG00000163930, Q92560, KIAA0272, hucep-6, HUCEP-13, FLJ37180, FLJ35406 AND Diagnosis
17 results:
1. The Prevalence and Radiologic Features of Renal Cancers Associated with
Charbel C; Causa Andrieu PI; Soliman M; Woo S; Zheng J; Capanu M; Nikolovski I; Vargas HA; Abusamra M; Carlo MI
Radiol Imaging Cancer; 2024 Mar; 6(2):e230063. PubMed ID: 38456787
[TBL] [Abstract] [Full Text] [Related]
2. bap1, Wilms' tumor 1, and calretinin in predicting survival and response to first-line chemotherapy in patients with pleural mesothelioma.
Yuce TH; Ak G; Metintas S; Dundar E; Roe OD; Panou V; Metintas M
J Cancer Res Clin Oncol; 2024 Jan; 150(2):38. PubMed ID: 38280040
[TBL] [Abstract] [Full Text] [Related]
3. A Rare Presentation of Aggressive Renal Cell Carcinoma and the Utility of Early Molecular Testing in Rapidly Progressing Malignancies: A Case Report.
McLoughlin DE; Chevalier N; Choy E; Cote GM; Gao X; Juric D; Reynolds KL
Oncologist; 2023 Dec; 28(12):1094-1099. PubMed ID: 37844295
[TBL] [Abstract] [Full Text] [Related]
4. Clinical practice guidelines for the diagnosis and surveillance of bap1 tumour predisposition syndrome.
Lalloo F; Kulkarni A; Chau C; Nielsen M; Sheaff M; Steele J; van Doorn R; Wadt K; Hamill M; Torr B; Tischkowitz M; ; Hanson H
Eur J Hum Genet; 2023 Nov; 31(11):1261-1269. PubMed ID: 37607989
[TBL] [Abstract] [Full Text] [Related]
5. [Hereditary renal tumor syndromes.].
Sánta F; Semjén D; Kuthi L
Orv Hetil; 2023 Mar; 164(10):363-375. PubMed ID: 36906860
[TBL] [Abstract] [Full Text] [Related]
6. Deciphering intratumor heterogeneity in clear cell renal cell carcinoma utilizing clinicopathologic and molecular platforms.
Vormittag-Nocito E; Mannan R; Wang X; Chinnaiyan A; Zhang Y; Zelenka-Wang S; Cao X; Morgan TM; Hafez K; Vaishampayan U; Abdulfatah E; Chinnaiyan AM; Dhanasekaran SM; Mehra R
Hum Pathol; 2022 Dec; 130():95-109. PubMed ID: 36511267
[TBL] [Abstract] [Full Text] [Related]
7. Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia.
Gupta S; Erickson LA; Lohse CM; Shen W; Pitel BA; Knight SM; Halling KC; Herrera-Hernandez L; Boorjian SA; Thompson RH; Leibovich BC; Jimenez RE; Cheville JC
JAMA Netw Open; 2021 Nov; 4(11):e2132615. PubMed ID: 34767027
[TBL] [Abstract] [Full Text] [Related]
8. Improving Renal Tumor Biopsy Prognostication With bap1 Analyses.
Kapur P; Setoodeh S; Araj E; Yan J; Malladi VS; Cadeddu JA; Christie A; Brugarolas J
Arch Pathol Lab Med; 2022 Jan; 146(2):154-165. PubMed ID: 34019633
[TBL] [Abstract] [Full Text] [Related]
9. Somatic Copy Number Alterations and Associated Genes in Clear-Cell Renal-Cell Carcinoma in Brazilian Patients.
Fernandes FG; Silveira HCS; Júnior JNA; da Silveira RA; Zucca LE; Cárcano FM; Sanches AON; Neder L; Scapulatempo-Neto C; Serrano SV; Jonasch E; Reis RM; Evangelista AF
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668731
[TBL] [Abstract] [Full Text] [Related]
10. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Trpkov K; Hes O; Williamson SR; Adeniran AJ; Agaimy A; Alaghehbandan R; Amin MB; Argani P; Chen YB; Cheng L; Epstein JI; Cheville JC; Comperat E; da Cunha IW; Gordetsky JB; Gupta S; He H; Hirsch MS; Humphrey PA; Kapur P; Kojima F; Lopez JI; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Menon S; Netto GJ; Przybycin CG; Rao P; Rao Q; Reuter VE; Saleeb RM; Shah RB; Smith SC; Tickoo S; Tretiakova MS; True L; Verkarre V; Wobker SE; Zhou M; Gill AJ
Mod Pathol; 2021 Jul; 34(7):1392-1424. PubMed ID: 33664427
[TBL] [Abstract] [Full Text] [Related]
11. Integrative genomic study of Chinese clear cell renal cell carcinoma reveals features associated with thrombus.
Wang XM; Lu Y; Song YM; Dong J; Li RY; Wang GL; Wang X; Zhang SD; Dong ZH; Lu M; Wang SY; Ge LY; Luo GD; Ma RZ; George Rozen S; Bai F; Wu D; Ma LL
Nat Commun; 2020 Feb; 11(1):739. PubMed ID: 32029730
[TBL] [Abstract] [Full Text] [Related]
12. Familial kidney Cancer: Implications of New Syndromes and Molecular Insights.
Carlo MI; Hakimi AA; Stewart GD; Bratslavsky G; Brugarolas J; Chen YB; Linehan WM; Maher ER; Merino MJ; Offit K; Reuter VE; Shuch B; Coleman JA
Eur Urol; 2019 Dec; 76(6):754-764. PubMed ID: 31326218
[TBL] [Abstract] [Full Text] [Related]
13. Exploring the hereditary background of renal cancer in Denmark.
Christensen MB; Wadt K; Jensen UB; Lautrup CK; Bojesen A; Krogh LN; Overeem Hansen TV; Gerdes AM
PLoS One; 2019; 14(4):e0215725. PubMed ID: 31034483
[TBL] [Abstract] [Full Text] [Related]
14. Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
Maher ER
World J Urol; 2018 Dec; 36(12):1891-1898. PubMed ID: 29680948
[TBL] [Abstract] [Full Text] [Related]
15. Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations.
Manley BJ; Reznik E; Ghanaat M; Kashan M; Becerra MF; Casuscelli J; Tennenbaum D; Redzematovic A; Carlo MI; Sato Y; Arcila M; Voss MH; Feldman DR; Motzer RJ; Russo P; Coleman J; Hsieh JJ; Hakimi AA
Urol Oncol; 2019 Jan; 37(1):12-17. PubMed ID: 29132830
[TBL] [Abstract] [Full Text] [Related]
16. Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, bap1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA.
Kluzek K; Srebniak MI; Majer W; Ida A; Milecki T; Huminska K; van der Helm RM; Silesian A; Wrzesinski TM; Wojciechowicz J; Beverloo BH; Kwias Z; Bluyssen HAR; Wesoly J
Oncotarget; 2017 Apr; 8(17):28558-28574. PubMed ID: 28212566
[TBL] [Abstract] [Full Text] [Related]
17. bap1 is overexpressed in black compared with white patients with Mx-M1 clear cell renal cell carcinoma: A report from the cancer genome atlas.
Paulucci DJ; Sfakianos JP; Yadav SS; Badani KK
Urol Oncol; 2016 Jun; 34(6):259.e9-259.e14. PubMed ID: 26854086
[TBL] [Abstract] [Full Text] [Related]
